JACQUELINE EHIMA: Open Payments
NPI 1922518026 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 7 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $425
Food & beverage: $412Education: $12
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $250 |
| ViiV Healthcare Company | 3 | $140 |
| Merck Sharp & Dohme LLC | 1 | $34 |
Products named: CABENUVA, Biktarvy, Yeztugo, PIFELTRO.
Industry payments across TX — which companies pay providers there.
